SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

EyePoint Pharmaceuticals, Inc. – ‘8-K’ for 9/29/22

On:  Thursday, 9/29/22, at 7:05am ET   ·   For:  9/29/22   ·   Accession #:  950170-22-18990   ·   File #:  0-51122

Previous ‘8-K’:  ‘8-K’ on / for 9/28/22   ·   Next:  ‘8-K’ on 10/11/22 for 10/7/22   ·   Latest:  ‘8-K’ on / for 3/7/24   ·   1 Reference:  By:  EyePoint Pharmaceuticals, Inc. – ‘S-8’ on 1/9/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/29/22  EyePoint Pharmaceuticals, Inc.    8-K:8,9     9/29/22   11:196K                                   Donnelley … Solutions/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     54K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     22K 
 6: R1          Document And Entity Information                     HTML     45K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 7: XML         XBRL Instance -- eypt-20220929_htm                   XML     15K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 5: EX-101.LAB  XBRL Labels -- eypt-20220929_lab                     XML     40K 
 3: EX-101.PRE  XBRL Presentations -- eypt-20220929_pre              XML     31K 
 4: EX-101.SCH  XBRL Schema -- eypt-20220929                         XSD     11K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               11±    17K 
11: ZIP         XBRL Zipped Folder -- 0000950170-22-018990-xbrl      Zip     18K 




        
Filing Submission 0000950170-22-018990 – SGML Text

Original SGML Text submitted by:  Donnelley Financial Solutions/FA  (as Filing Agent) 

To view the SGML, please refresh
Refresh emoji
this page.


Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 3, 8:20:22.2am ET